Heinz-Josef Lenz
University of Southern California · City of Hope Medical Center · U.S.C./Norris Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Heinz-Josef Lenz as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:29 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06063928 · Confronting Cancer as a CommunityUniversity of Southern California · recruiting · Colorectal Carcinoma · principal investigator
- Ph2NCT04373044 · Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19University of Southern California · terminated · Symptomatic COVID-19 Infection Laboratory-Confirmed · principal investigator
- Ph1/Ph2NCT03657641 · Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal CancerUniversity of Southern California · active not recruiting · Colorectal Cancer, Colorectal Cancer Metastatic · principal investigator
- N/ANCT03594448 · Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma PatientsUniversity of Southern California · terminated · Microsatellite Instability, Colorectal Cancer Stage IV
- Ph1/Ph2NCT03576963 · Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal CancerUniversity of Southern California · withdrawn · Colorectal Adenocarcinoma, CpG Island Methylator Phenotype, Metastatic Microsatellite Stable Colorectal Carcinoma · principal investigator
- Ph2NCT02413853 · Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal CancerUniversity of Southern California · withdrawn · Colorectal Adenocarcinoma, Stage IVA Colorectal Cancer, Stage IVB Colorectal Cancer · principal investigator
- Ph1NCT01238965 · Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based ChemotherapyUniversity of Southern California · terminated · Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer · principal investigator
- N/ANCT00900172 · Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and PaclitaxelECOG-ACRIN Cancer Research Group · completed · Lung Cancer · study chair
- Ph2NCT00459108 · Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by SurgeryNational Cancer Institute (NCI) · terminated · Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer · principal investigator
- N/ANCT00283257 · Simultaneous Care: Linking Palliation to Clinical TrialsUniversity of California, Davis · completed · Solid Tumor, Lymphoma
- Ph1NCT00183833 · Study of Xeloda and Gleevec in Patients With Advanced Solid TumorsUniversity of Southern California · completed · Colon Cancer, Colorectal Cancer · principal investigator
- Ph1/Ph2NCT00159484 · Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal CancerUniversity of Southern California · completed · Colon Cancer, Colorectal Cancer · principal investigator
- Ph2NCT00114244 · Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic CancerNational Cancer Institute (NCI) · completed · Stage IV Pancreatic Cancer · principal investigator
- Ph2NCT00103103 · Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach CancerCalifornia Cancer Consortium · terminated · Gastric Cancer · study chair
- Ph2NCT00006037 · Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal CancerUniversity of Southern California · terminated · Colorectal Cancer · study chair
- Ph1NCT00007878 · Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryNational Cancer Institute (NCI) · completed · Unspecified Adult Solid Tumor, Protocol Specific · principal investigator
- Ph2NCT00070434 · S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the RectumSWOG Cancer Research Network · withdrawn · Colorectal Cancer · study chair
- Ph2NCT00068380 · A Phase II Trial of STI571 in the Treatment of Metastatic Gastric CancerNational Cancer Institute (NCI) · completed · Recurrent Gastric Cancer, Stage IV Gastric Cancer · principal investigator
- Ph1NCT00005839 · Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid TumorCity of Hope Medical Center · completed · Unspecified Adult Solid Tumor, Protocol Specific · study chair
- Ph1NCT00004243 · Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid TumorCity of Hope Medical Center · completed · Unspecified Adult Solid Tumor, Protocol Specific · study chair
- Ph2NCT00033540 · S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or CholangiocarcinomaSWOG Cancer Research Network · completed · Extrahepatic Bile Duct Cancer, Gallbladder Cancer · study chair
- Ph2NCT00049335 · S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically RemovedSWOG Cancer Research Network · completed · Colorectal Cancer · study chair
- Ph2NCT00006389 · Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach CancerNational Cancer Institute (NCI) · completed · Stage III Gastric Cancer, Stage IV Gastric Cancer · principal investigator
- N/ANCT00003843 · Irinotecan in Treating Patients With Colorectal CancerCalifornia Cancer Consortium · terminated · Colorectal Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Research Training and Education CoordinationP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Josh Neman-Ebrahim · fiscal years 2006 to 2026
- Efficacy of Novel Wnt Modulator in Colon CancerR01CA166161 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Michael Kahn, HEINZ JOSEF LENZ · fiscal years 2013 to 2017Named on NCT02413853
- Phase I Molecular and Clincal Pharmacodynamic TrialsU01CA062505 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI EDWARD M NEWMAN · fiscal years 2006 to 2013
- Southwest Oncology Group Treatment GrantU10CA032102 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHARLES D. BLANKE · fiscal years 2006 to 2013
Most cited trial papers
Clinical-trial papers with this author name in colorectal cancer, ranked by citations from NIH iCite, fetched 2026-11-12 12:29 UTC. The ranking covers the 200 most relevant of 101 PubMed records, and a shared surname and initials can bring in a namesake. All 101 on PubMed
- 2,408 citationsRCR 68.5
- 2,327 citationsRCR 75.2
- Randomized trial of TAS-102 for refractory metastatic colorectal cancer.N Engl J Med · 20151,193 citationsRCR 36.1
- 779 citationsRCR 25.4
- Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.Clin Cancer Res · 2000764 citationsRCR 16.3
- EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer.J Clin Oncol · 2008763 citationsRCR 17.3
- Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer.J Clin Oncol · 2015677 citationsRCR 20.1
- First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study.J Clin Oncol · 2022615 citationsRCR 41.9
- Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.J Clin Oncol · 2006424 citationsRCR 9.7
- 385 citationsRCR 7.8